Zydus announces phase-IV Dream-CKD trial to generate real-world evidence of Desidustat in patients with CKD-induced anaemia Read more
Zydus Cadila Desidustat’s better positioned to get first-to-market advantage within HIF-PHI class in India, says GlobalData Read more
Zydus’ Desidustat efficacious in treating hypoxia in Mexico’s hospitalised COVID-19 patients: Study Read more